[ad_1]
Johnson & Johnson declined to comment on a report that the U.S. Food and Drug Administration said it has disposed of 60 million doses of a COVID-19 vaccine that was produced at a troubled facility in Maryland due to concerns about possible contamination. The report, published by the New York Times, cited people familiar with the situation and comes as the US Food and Drug Administration said it had authorized two batches of the vaccine produced at its Emergent BioSolutions facility in Baltimore but found “several other batches” unsuitable for use.
The FDA also noted in a press release published Friday that “the additional batches are still under review and the agency will inform the public once those reviews are complete.” At this time, the agency said it was “not yet ready to include the Emergent BioSolutions plant in Janssen EUA as an approved manufacturing facility.” “,” she continues, “to work through the issues there with Janssen management and Emergent BioSolutions.”
Click here for full coverage of the coronavirus
A Johnson & Johnson spokesperson declined to comment on Fox News on the matter.
This is an evolving story, please keep checking back for updates.
[ad_2]
Picture Credit!